A novel experimental drug in Major Depression

 An article published this month in the journal Biological Psychiatry, describes the results obtained with treatment-resistant major depressive disorder patients, who received a single dose of AZD6765, a low-trapping N-methyl-D-aspartate antagonist experimental drug.These patients rapidly improved depression symptoms, compared to vehicle treated patients, and no psychotomimetic effects were observed. However, this improvement was for a very short time.

 

Further studies are required to test AZD6765 effects at repeated doses.

 

Be Sociable, Share!